1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC3367 |
Quality Control | All cell lots test negative for HIV-1, HBV, HCV, mycoplasma, yeast, fungi, and other pathogens. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Monocyte |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Cord Blood |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Cord Blood Cells |
Key Features | – Backed by AcceGen advanced technology – Cryopreserved for highest viability and plating efficiency – Quality-guaranteed for accurate results – Timely technical support for best experimental outcomes |
Human Cord Blood CD14⁺ Monocytes are primary immune cells isolated from healthy human umbilical cord blood and belong to the monocyte lineage. Characterized by high CD14 expression and variable CD16, they display round or oval morphology, granular cytoplasm, and suspension growth. These non-proliferative cells are precursors to macrophages and dendritic cells, capable of phagocytosis, antigen presentation, and cytokine secretion (e.g., TNF-α, IL-6). Involved in host defense, inflammation, autoimmune diseases, and transplant immunology, they play a central role in both innate and adaptive immunity. These cells are express of CD14, CD16, and HLA-DR. Their responsiveness to pathogens makes them ideal for studying immune responses and monocyte-to-macrophage differentiation.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Cord Blood CD14+ Monocytes can be used to study monocyte-macrophage differentiation, innate immune response, and inflammatory regulation mechanisms. They can also be used to study TLR signaling pathways, cell polarization (e.g., M1/M2 macrophages), and immune metabolic reprogramming mechanisms. In addition, CD14+ monocytes can be employed in the development cell-based therapies, such as the in vitro induction of anti-inflammatory macrophages for potential treatment of inflammatory diseases such as colitis.